Stella delivers comprehensive mental health care through a multidisciplinary team of board-certified physicians, psychiatric nurse practitioners, psychologists, and advocates across more than 35 U.S. locations as well as sites in Israel and Australia. The company offers multiple treatment protocols and modalities, including Ketamine Infusion Therapy and the SOF Protocol combining ketamine and DSR. Stella has treated over 6,000 patients to date and recently opened a flagship facility in Chicago that will serve as a hub for innovative treatments, research, medical training, and clinical trials. Founded in 2020 and led by CEO Philippe Sanchez, the company emphasizes responsible innovation in mental health care. Financially, Stella announced a $7M funding raise to support its growth and research initiatives. The company plans to use the proceeds to advance mental health research and expand locations across the U.S. and internationally.

Total raised

$7M

Funding rounds

1

Latest round

Equity

Latest activity

May 2023